Efficacy, Safety, and Tolerability of V937 Administered Intravenously or Intratumorally With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone in Participants With Advanced/Metastatic Melanoma (V937-011)
Pembrolizumab (MK-3475) Versus Placebo Following Surgery and Radiation in Participants With Locally Advanced Cutaneous Squamous Cell Carcinoma (MK-3475-630/KEYNOTE-630)
~91 mi.
(Valence,
France,
+137 more cities)
Centre Hospitalier de Valence-Service de Dermatologie ( Site 0377)
A Study of Atezolizumab Versus Placebo as Adjuvant Therapy in Patients With High-Risk Muscle-Invasive Bladder Cancer Who Are ctDNA Positive Following Cystectomy
~97 mi.
(Orbassano,
Italy,
+120 more cities)
A.O. UNIVERSITARIA S. LUIGI GONZAGA; Oncologia Medica